Open Access

Heme oxygenase‑1 alleviates advanced glycation end product‑induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts

  • Authors:
    • Qingling Li
    • Shangyan Liang
    • Qianwei Lai
    • Lishan Shen
    • Yong Zhang
    • Ruomi Guo
  • View Affiliations

  • Published online on: August 24, 2021     https://doi.org/10.3892/etm.2021.10646
  • Article Number: 1212
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Advanced glycation end products (AGEs) are involved in delaying the wound healing of diabetic foot ulcers. The present study investigated the effects of heme oxygenase‑1 (HO‑1) on oxidative stress, inflammatory insult and biological behaviors in rat dermal fibroblasts in the presence of AGEs. Rat dermal fibroblasts were cultured in the presence of AGEs (100 µg/ml), glucose (1.0 g/l or 4.5 g/l), hemin (5 µM) and chromium mesoporphyrin (CrMP; 20 µM). A bilirubin kit, reverse transcription‑quantitative PCR and western blotting were used to measure the activity and mRNA and protein levels of HO‑1, respectively. ELISA kits were used to measure the levels of reactive oxygen species (ROS), malondialdehyde (MDA), 8‑hydroxydeoxyguanosine (8‑OHdG), TNF‑α, IL‑6, IL‑1β and the viability and collagen (hydroxyproline) secretion of fibroblasts. Cell proliferation and apoptosis were measured via flow cytometry. The scratch test was performed to evaluate cell migration. The results revealed that AGEs resulted in oxidative stress, inflammatory response and biological behavioral disorders in fibroblasts, while worsened functional disorders were caused by the combination of AGEs and high‑glucose treatment. Hemin treatment induced sustained high HO‑1 expression, decreased the levels of ROS, MDA, 8‑OHdG, TNF‑α, IL‑6, IL‑1β and cell apoptosis, and increased cellular collagen synthesis, viability, proliferation and migration, whereas CrMP abolished the effects of hemin. It was observed that high HO‑1 expression reversed the AGE‑induced oxidative stress, inflammatory response and biological behavioral disorders in fibroblasts, but fibroblast function did not return to that observed under normal glucose levels. In conclusion, it was demonstrated that hemin treatment induced high HO‑1 expression. HO‑1 reduced the AGE‑induced functional disorders in fibroblasts and may accelerate the healing of diabetic wounds by improving fibroblast biological behaviors and reducing the oxidative stress and inflammatory response.
View Figures
View References

Related Articles

Journal Cover

November-2021
Volume 22 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Q, Liang S, Lai Q, Shen L, Zhang Y and Guo R: Heme oxygenase‑1 alleviates advanced glycation end product‑induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts. Exp Ther Med 22: 1212, 2021
APA
Li, Q., Liang, S., Lai, Q., Shen, L., Zhang, Y., & Guo, R. (2021). Heme oxygenase‑1 alleviates advanced glycation end product‑induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts. Experimental and Therapeutic Medicine, 22, 1212. https://doi.org/10.3892/etm.2021.10646
MLA
Li, Q., Liang, S., Lai, Q., Shen, L., Zhang, Y., Guo, R."Heme oxygenase‑1 alleviates advanced glycation end product‑induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts". Experimental and Therapeutic Medicine 22.5 (2021): 1212.
Chicago
Li, Q., Liang, S., Lai, Q., Shen, L., Zhang, Y., Guo, R."Heme oxygenase‑1 alleviates advanced glycation end product‑induced oxidative stress, inflammatory response and biological behavioral disorders in rat dermal fibroblasts". Experimental and Therapeutic Medicine 22, no. 5 (2021): 1212. https://doi.org/10.3892/etm.2021.10646